First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
AVM Biotechnology Inc
Orca Biosystems, Inc.
Vironexis Biotherapeutics Inc.
Syndax Pharmaceuticals
Ossium Health, Inc.
Orca Biosystems, Inc.
Meryx, Inc.